The European Medicines Agency is also working in developing the key principles to implement the electronic product information, to provide a digital platform for the information related to medicines authorised in the EU, how they should be used and prescribed in the different European languages. As a way of gathering public opinion, the EMA has launched a consultation on this subject (deadline 31 July 2019). Another consultation that was also recently launched was on Regulatory science to 2025, which places as a goal to advance on patient-centred access to medicines. This consultation is open until 30 June 2019.
On-going work on the European clinical trials portal and database
6 December 2018
The EMA continues to collaborate with member states representatives, pharmaceutical companies, healthcare professionals and patient organisations to develop the system that would enable the creation and use of the European clinical trials portal and database, as established in European legislation. At present, the focus is on the last phase of the software testing process, to ensure the software can handle the requirements in real scenarios according to what was settled in legislation.